Blue Chip Giants PG, JNJ, and KO Poised for Surprise Growth in 2027

Three stalwart dividend payers, Procter & Gamble (NYSE:PG), Johnson & Johnson (NYSE:JNJ), and Coca-Cola (NYSE:KO), are poised to surprise investors in 2027 with potential price targets of $180, $300, and $100 respectively.

The trio has demonstrated resilience in the face of a recessionary consumer sentiment level of 49.5%, with staples and healthcare names gaining relevance as shoppers trade down. PG trades near 22x earnings, in line with the market, while JNJ needs roughly 17% more upside to hit $300.

PG's productivity plan, JNJ's oncology pipeline, and KO's World Cup activation serve as distinct catalysts for these defensive giants. Oncology is driving growth at JNJ, with DARZALEX increasing by 22.5%, TREMFYA jumping 68.3%, and RYBREVANT/LAZCLUZE surging 82.7% in Q1.

With healthcare spending rising $203.3B year-over-year to $3,741.0B, and nondurable goods spending climbing $271.2B, tailwinds directly benefit this trio.